IRIS
GHIORZO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 22.338
AS - Asia 2.557
NA - Nord America 2.269
Continente sconosciuto - Info sul continente non disponibili 518
SA - Sud America 209
AF - Africa 31
OC - Oceania 13
Totale 27.935
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 21.891
US - Stati Uniti d'America 2.118
SG - Singapore 971
CN - Cina 636
VN - Vietnam 408
BD - Bangladesh 299
FR - Francia 190
BR - Brasile 125
HK - Hong Kong 84
FI - Finlandia 67
CA - Canada 63
DE - Germania 51
AR - Argentina 39
JP - Giappone 32
GB - Regno Unito 26
CH - Svizzera 24
MX - Messico 23
IQ - Iraq 22
IN - India 17
NL - Olanda 17
AU - Australia 13
CR - Costa Rica 12
CO - Colombia 11
PL - Polonia 11
RU - Federazione Russa 11
HN - Honduras 10
ID - Indonesia 10
GT - Guatemala 9
JM - Giamaica 9
TT - Trinidad e Tobago 9
CL - Cile 8
UZ - Uzbekistan 8
ES - Italia 7
IE - Irlanda 7
VE - Venezuela 7
EC - Ecuador 6
MA - Marocco 6
PK - Pakistan 6
SA - Arabia Saudita 6
TR - Turchia 6
GR - Grecia 5
MY - Malesia 5
PY - Paraguay 5
ZA - Sudafrica 5
AT - Austria 4
AZ - Azerbaigian 4
IR - Iran 4
JO - Giordania 4
KR - Corea 4
NI - Nicaragua 4
PH - Filippine 4
SV - El Salvador 4
TH - Thailandia 4
UA - Ucraina 4
UY - Uruguay 4
CZ - Repubblica Ceca 3
DZ - Algeria 3
EG - Egitto 3
IL - Israele 3
LT - Lituania 3
OM - Oman 3
AE - Emirati Arabi Uniti 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
KE - Kenya 2
KZ - Kazakistan 2
NP - Nepal 2
PE - Perù 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SE - Svezia 2
SI - Slovenia 2
SN - Senegal 2
TN - Tunisia 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AL - Albania 1
BE - Belgio 1
BM - Bermuda 1
BO - Bolivia 1
CY - Cipro 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KY - Cayman, isole 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
ML - Mali 1
MM - Myanmar 1
MT - Malta 1
MW - Malawi 1
NG - Nigeria 1
QA - Qatar 1
Totale 27.413
Salva come PNG Salva come JPEG
Città #
Genova 12.035
Genoa 6.110
Rapallo 1.921
Vado Ligure 1.471
San Jose 461
Singapore 430
Ashburn 318
Lauterbourg 177
Council Bluffs 133
Ho Chi Minh City 128
Beijing 110
Hanoi 93
New York 90
Hong Kong 80
Helsinki 63
Santa Clara 57
Milan 52
Bordighera 46
Frankfurt am Main 44
Los Angeles 38
Buffalo 28
Rome 24
Tokyo 24
Dallas 23
Zurich 21
São Paulo 20
Haiphong 18
Chicago 17
Atlanta 16
Bologna 15
Phoenix 15
Montreal 14
Naples 14
Philadelphia 14
Tianjin 14
Baghdad 13
Boardman 13
Houston 13
Mexico City 13
London 12
Da Nang 11
Orem 11
San Antonio 11
San Francisco 11
Brooklyn 10
Miami 10
Amsterdam 9
Charlotte 8
Denver 8
Guatemala City 8
San José 8
Warsaw 8
Biên Hòa 7
Detroit 7
Dublin 7
Hải Dương 7
Toronto 7
Athens 6
Buenos Aires 6
Catania 6
Cleveland 6
Des Moines 6
Guangzhou 6
Palermo 6
Seattle 6
Vienna 6
Bari 5
Brasília 5
Can Tho 5
Florence 5
Minneapolis 5
Phủ Lý 5
Queens 5
Rio de Janeiro 5
Tampa 5
Tashkent 5
The Bronx 5
Thái Nguyên 5
Venice 5
Washington 5
Albany 4
Alexandria 4
Asunción 4
Baku 4
Boston 4
Carriere 4
Chennai 4
Columbus 4
Elgin 4
Gaithersburg 4
Hưng Yên 4
Kingston 4
Land O' Lakes 4
Lappeenranta 4
Las Vegas 4
Managua 4
Mumbai 4
Newark 4
Ocala 4
Orlando 4
Totale 24.550
Salva come PNG Salva come JPEG
Nome #
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 260
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. 246
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients 242
BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies. 236
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. 233
A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer 227
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. 222
Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppression. 221
Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study 220
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations 219
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients 219
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. 218
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients 215
Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT 210
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma 209
An upstream positive regulatory element in human GM-CSF promoter is recognized by NF-kB/Rel family members 209
Functional annotation and investigation of the 10q24.33 melanoma risk locus identifies a common variant that influences transcriptional regulation of OBFC1 207
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: A pooled-analysis from the M-SKIP project. 206
Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup 203
Incidence of other neoplasia in Italian melanoma-prone families with p16 (GLy93Trp) mutation 201
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL 200
Analysis of the Expression and Single-Nucleotide Variant Frequencies of the Butyrophilin-like 2 Gene in Patients With Uveal Melanoma 199
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma 198
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma. 197
Association of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip Project 195
The effect on melanoma risk of genes previously associated with telomere length. 194
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma 194
PCCR: Pancreatic Cancer Collaborative Registry. 193
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 192
c-Rel and p65 subunits bind to an upstream NF-kB site in human granulocyte macrophage-colony stimulating factor promoter involved in phorbol ester response in 5637 cells 191
Cell-type–specific eQTL of primary melanocytes facilitates identification of melanoma susceptibility genes 191
Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients 189
Association of Genetic Variants in CDK6 and XRCC1 with the Risk of Dysplastic Nevi in Melanoma-Prone Families. 188
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL) 188
A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindreds 187
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148 187
Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLDmutation in Brenner tumor 186
Intersociety policy statement on the use of whole-exome sequencing in the critically ill newborn infant 186
Gly101Trp germline mutation in the CDKN2A gene in familial and non familial Ligurian melanoma patients 183
ANALISI GENOME-WIDE PER LA SUSCETTIBILITÀ AL MELANOMA: NUOVI LOCICHE CONFERMANO IL RUOLO DEI GENI DELLA PIGMENTAZIONE 180
A variant in FTO shows association with melanoma risk not due to BMI. 179
Uncommon association of germline mutations of RET proto-oncogene and CDKN2A gene 177
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide 177
Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents 176
Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis. 174
Identification, genetic testing, and management of hereditary melanoma 173
Alcohol and Tobacco Lower the Age of Presentation in Sporadic Pancreatic Cancer in a Dose-Dependent Manner: A Multicenter Study. 173
Molecular characterization of an Italian series of sporadic GISTs. 170
The CDKN2A/p16INK4a 5'UTR sequence and translational regulation: Impact of novel variants predisposing to melanoma 168
Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma. 165
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma 165
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. 165
Clinical genetic testing for familial melanoma in Italy: a cooperative study. 164
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort 163
Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer 163
Mutational concordance between primary and metastatic melanoma: A next-generation sequencing approach 163
Genome-wide association study identifies three new melanoma susceptibility loci 163
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. 160
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome 159
Current State of Target Treatment in BRAF Mutated Melanoma 159
Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in acd, atm, bap1, and pot1 158
Absence of high risk gene mutations in hereditary melanoma points to the interplay between somatic and low risk germline variants 157
Signs and genetics of rare cancer syndromes with gastroenterological features 157
MelaNostrum: A Consensus Questionnaire of Standardized Epidemiologic and Clinical Variables for Melanoma Risk Assessment by the MelaNostrum Consortium 157
Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions. 157
High prevalence of the G101W germline mutation in the CDKN2A (P16INK4A) gene in 62 Italian malignant melanoma families 157
Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations [Oncotarget. 2018; 9:5691-5702]doi 10.18632/oncotarget.23204 157
Genetic testing for melanoma 156
Varianti polimorfiche del gene MC1R (Melanocortin receptor 1) nella popolazione ligure ed associazione con il rischio di melanoma 155
Functional analysis of a CDKN2A 5’UTR germline variant associated with pancreatic cancer development 155
Meta-analysis combining new and existing data sets confirms that the TERT-CLPTM1L locus influences melanoma risk. 155
Analysis of p16 protein expression in familial melanoma patients: correlation with germline status. 154
CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma 152
Identification of a SUFU germline mutation in a family with Gorlin syndrome 150
Somatic BRAF and NRAS Mutations in Familial Melanomas with Known Germline CDKN2A Status: A GenoMEL Study. 150
Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls 150
High prevalence of the Gly101Trp germline mutation in the CDKN2A gene in 62 small Italian families 149
The 5′-untranslated region of p16INK4a acts as a cellular IRES, controls mRNA translation during hypoxic and energetic stresses, and is a target of YBX1 149
3’UTR polymorphisms in the CDKN2A gene and age at onset of familial and sporadic melanoma 148
MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients. 148
Coexisting NRAS and BRAF Mutations in Primary Familial Melanomas with Specific CDKN2A Germline Alterations. 147
Italian Melanoma-prone Families:Germline mutational analysis and Clinical-Epidemiological Characterization 146
CDKN2A germline mutation analysis in patients with pancreatic adenocarcinoma 145
Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families. 145
Hereditary trichilemmal cysts: A proposal for the assessment of diagnostic clinical criteria 145
Linkage Analysis in melanoma prone families 144
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup Study 144
The 5'-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding 144
3’UTR polymorphisms in the CDKN2A gene and age at onset of familial and sporadic melanoma from Liguria 144
Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families 143
Five novel germline function-impairing mutations of CYLD in Italian patients with multiple cylindromas 143
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 142
Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma 142
Characterization of Ligurian Melanoma families and risk of occurence of other neoplasia 142
Mutation screening of the CDKN2A promoter melanoma families 140
Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studies 140
Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways 139
Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations 138
Impact of novel CDKN2A/p16INK4a 5’UTR variants predisposing to melanoma on p16 translational regulation 138
The Microphthalmia-Associated Transcription Factor p.E318K Mutation Does Not Play a Major Role in Sporadic Renal Cell Tumors from Caucasian Patients 137
Totale 17.516
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.685
article - articoli 80.677
book - libri 0
conference - conferenze 11.797
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.211
Totale 187.370
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.200 94 174 130 244 90 169 166 495 94 209 83 252
2022/20232.338 269 153 25 235 430 362 17 187 385 16 217 42
2023/20241.268 52 153 20 139 76 205 96 76 97 36 76 242
2024/20253.762 121 266 150 275 472 365 402 601 170 172 300 468
2025/20267.426 734 260 888 563 828 663 1.011 273 559 688 534 425
2026/2027687 687 0 0 0 0 0 0 0 0 0 0 0
Totale 27.935